FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Hydrocortisone Sodium Succinate Injection
Status: Currently in Shortage
»Date first posted: 03/24/2023
»Therapeutic Categories: Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology

Expand all

Hospira, Inc., a Pfizer Company (Revised 05/15/2024)

Company Contact Information:
844-646-4398

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Solu-cortef, Injection, 1000 mg/vial (NDC 0009-0005-01)	Available
Solu-cortef, Injection, 100 mg/vial (NDC 0009-0825-01)	Limited Availability	Limited Supply Available. Next Delivery: May 2024; Estimated Recovery: September 2024; Shortage per Manufacturer: Manufacturing Delay	Delay in shipping of the drug
Solu-cortef, Injection, 100 mg/vial (NDC 0009-0011-04)	Available
Solu-Cortef, Injection, 100 mg/vial (NDC 0009-0011-03)	Available
Solu-cortef, Injection, 250 mg/vial (NDC 0009-0013-06)	Available
Solu-cortef, Injection, 250 mg/vial (NDC 0009-0013-05)	Available
Solu-cortef, Injection, 500 mg/vial (NDC 0009-0016-12)	Available